Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Operating Leases (2019 - 2025)

Historic Operating Leases for Veracyte (VCYT) over the last 7 years, with Q3 2025 value amounting to $40.5 million.

  • Veracyte's Operating Leases rose 10540.77% to $40.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.5 million, marking a year-over-year increase of 10540.77%. This contributed to the annual value of $43.2 million for FY2024, which is 47457.81% up from last year.
  • Per Veracyte's latest filing, its Operating Leases stood at $40.5 million for Q3 2025, which was up 10540.77% from $50.6 million recorded in Q2 2025.
  • Veracyte's 5-year Operating Leases high stood at $50.6 million for Q2 2025, and its period low was $7.5 million during Q4 2023.
  • For the 5-year period, Veracyte's Operating Leases averaged around $21.8 million, with its median value being $16.5 million (2022).
  • Per our database at Business Quant, Veracyte's Operating Leases tumbled by 2932.95% in 2023 and then skyrocketed by 47457.81% in 2024.
  • Veracyte's Operating Leases (Quarter) stood at $14.1 million in 2021, then fell by 24.46% to $10.6 million in 2022, then fell by 29.33% to $7.5 million in 2023, then surged by 474.58% to $43.2 million in 2024, then fell by 6.44% to $40.5 million in 2025.
  • Its Operating Leases was $40.5 million in Q3 2025, compared to $50.6 million in Q2 2025 and $50.5 million in Q1 2025.